Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative intravenous iron therapy in patients with gastric cancer
2019-001005-25Phase 4Active
- Sponsor
- Helsinki University Hospital
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ferric carboxymaltose in gastric cancer (GC), sponsored by Helsinki University Hospital. Primary endpoint: Need for blood transfusion. Started Aug 2019; status: active.
02
Drugs
ferric carboxymaltose
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on 2019-001005-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001005-25.